In PAH patients, increased levels of circulating pro-inflammatory cytokines (e.g., IL-1β, TNF-α) have been correlated to the severity of the disease (Humbert et al., 1995; Dolenc et al., 2014), which also reinforces the vicious circle between inflammation and RV failure. This evidence concerns the gene TNF and pulmonary arterial hypertension.